127 / 140
125
NOTE 27.6 SEGMENT INFORMATION
(a) Primary Segment – Business
(
`
cr)
Particulars
Life Science
Chemicals
Performance &
Other Chemicals
Total
2011-12 2010-11 2011-12 2010-11 2011-12 2010-11
1 Segment revenues
Gross sales
654.56 532.14 1,377.50 1,204.57 2,032.06 1,736.71
Less: Inter segment revenues
-
- 132.46 120.03
132.46
120.03
Net revenues from operations
654.56 532.14 1,245.04 1,084.54 1,899.60 1,616.68
2 Segment results
Profit before finance cost and tax
109.25
90.20
84.49
73.42 193.74
163.62
Finance cost
43.31
26.30
Other unallocable expenditure
(net of unallocable income)
20.36
(1.55)
Profit before tax
130.07
138.87
3 Other information
Segment assets
347.90 267.18 774.37 697.63 1,122.27
964.81
Unallocated common assets
342.48
300.03
Total assets
1,464.75 1,264.84
Segment liabilities
90.63
80.42 252.11 215.36
342.74
295.78
Unallocated common liabilities
65.05
67.32
Total liabilities
407.79
363.10
Capital expenditure
36.62
6.60
95.28
44.06
131.90
50.66
Unallocated capital expenditure
6.58
1.53
Total capital expenditure
138.48
52.19
Depreciation
10.29
9.06
29.28
27.11
39.57
36.17
Unallocated depreciation
4.45
2.47
Total depreciation
44.02
38.64
Significant non-cash expenses
-
-
-
-
-
-
Significant - unallocated non-cash
expenses
-
-
Total significant non-cash expenses
-
-
(b) Secondary Segment-Geographica
l
(
`
cr)
Particulars
In India
Outside India
Total
2011-12 2010-11 2011-12 2010-11 2011-12 2010-11
Segment revenues
1,094.08 949.22 805.52 667.46 1,899.60 1,616.68
Carrying cost of assets by location of
assets
1,291.71 1,160.05 173.04 104.79 1,464.75 1,264.84
Additions to assets and intangible
assets
138.48
52.19
-
-
138.48
52.19
Other disclosures
1 Segments have been identified in line with the Accounting Standard-17 ‘Segment Reporting’ taking into
account the organisation structure as well as the differing risks and returns.
2 The Company has disclosed business segment as the primary segment.
Notes
to Consolidated financial statements